Robert Fey
Overview
Explore the profile of Robert Fey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Biliouris K, Gaitonde P, Yin W, Norris D, Wang Y, Henry S, et al.
CPT Pharmacometrics Syst Pharmacol
. 2018 Jul;
7(9):581-592.
PMID: 30043511
A pharmacokinetic (PK) model was developed for nusinersen, an antisense oligonucleotide (ASO) that is the first approved treatment for spinal muscular atrophy (SMA). The model was built with data from...
2.
Henry S, Johnson M, Zanardi T, Fey R, Auyeung D, Lappin P, et al.
Toxicology
. 2012 Jun;
301(1-3):13-20.
PMID: 22709826
The primary target organ for uptake of systemically administered phosphorothioate oligonucleotides is the kidney cortex and the proximal tubular epithelium in particular. To determine the effect of oligonucleotide uptake on...
3.
Fan X, Venegas R, Fey R, van der Heyde H, Bernard M, Lazarides E, et al.
Pharm Res
. 2007 Mar;
24(5):868-79.
PMID: 17377744
Purpose: The goals in this study were several-fold. First, to optimize the in vivo phage display methodology by incorporating phage pharmacokinetic properties, to isolate peptides that target the brain microvasculature,...